THE PILLARS THAT SUPPORT US

Similar documents
BIOMÉRIEUX A PIONEER FOR INNOVATION - SEPTEMBER FROM A. MÉRIEUX INTERVIEW WITH FEATURE FEATURE (2) IN ACTION IN ACTION (2) DID YOU KNOW?

Welcome to Althea. Welcome to the future of integrated healthcare technology management

Strategic Plan. A WORLD CLASS university creating social and economic impact through science, technology and innovation.

Imagine your future lab. Designed using Virtual Reality and Computer Simulation

(Fig.) JPMA Industry Vision 2025

Introducing the Calgary Public Library Foundation

of Temperatures and other Physical Parameters

COURSE 2. Mechanical Engineering at MIT

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Towards a World in Common Strategy. #WorldInCommon

TAB V. VISION 2030: Distinction, Access and Excellence

Philanthropy Impacts THE UNIVERSITY OF SOUTH FLORIDA

Corporate Mind 2013 Corporate Responsibility Report

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Epilogue. Simona Rocchi Erasmus University, Centre for Environmental Studies, Rotterdam

Passionate about making a difference? Create the future with Arcadis

WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP?

Sample Thank You Letters

Corporate Mind 2015 Corporate Responsibility Report

The Biological and Medical Sciences Research Infrastructures on the ESFRI Roadmap

GE Healthcare. Vivid S5. Cardiovascular ultrasound system

Commission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )

Enabling ICT for. development

Strategic Plan UNIGE The University of Geneva in 2025

FOR RELEASE MAY 19, 2016

Science with Arctic Attitude

Expert. Innovative. Human. Global. Responsible

Speaking with One Voice Unifying Scripps Under a Master Brand Strategy

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA

A GLOBAL REACH MEDIA KIT

Create for the future

GE Healthcare. 9100c. Familiar. Reliable. Affordable.

ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020

Strategic Planning Framework

Make an Executive Decision to Fight Cancer.

Higher Education Contribution to Health Science Innovation

THEME 4 Creating Innovative Approaches to Local and Global Challenges

EPSRC Funding for Engineering

Well-poised to become a dominant real estate player with potentially the largest portfolio of HSR projects

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Appendix 2 Statoil: About our brand. 14 pages

Creativity, Collaboration and Identity. Program for an EHRA presidency. Christophe Leclercq

POSITION PAPER. GREEN PAPER From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation funding

G7 SCIENCE MINISTERS COMMUNIQUÉ

Universities and Sustainable Development Towards the Global Goals

MILAN DECLARATION Joining Forces for Investment in the Future of Europe

THE BIOMEDICAL ENGINEERING TEACHING & INNOVATION CENTER. at Boston University s College of Engineering

THE CENTER FOR WOMEN S ENTREPRENEURIAL LEADERSHIP AT BABSON

The global leader in trusted identities for an increasingly digital world. Press kit September, 28 th 2017

Higher School of Economics, Vienna

Heinrich Jessen, Chairman, Jebsen & Jessen (SEA)

Roche in Mannheim. The high-tech campus

The Developing World and the Role of Information and. Communication Technologies

ENGINEERS, TECHNICIANS, ICT EXPERTS

e-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0)

Grenoble 13 July 2016 ARAYMOND, A HISTORY OF INDUSTRIAL AND HUMAN INNOVATION

USTGlobal. 3D Printing. Changing the Face of Healthcare

Copernicus Evolution: Fostering Growth in the EO Downstream Services Sector

Desert Healthcare District Director reflects on 18 years of service

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

Colombia on the Frontier of Biomedicine. Zagaya

WFEO STANDING COMMITTEE ON ENGINEERING FOR INNOVATIVE TECHNOLOGY (WFEO-CEIT) STRATEGIC PLAN ( )

They all say it is about the economy. It is more than ratio s, percentages, and growth; it is about the Lives of people

Horizon Europe structure and budget allocation Helen Fairclough UK National Contact Point

Corporate. We move mountains. MTONGA & ASSOCIATES PRIVATE LIMITED Civil Engineering: Designing & Construction

IEEE Smart Cities Initiative

SPECIAL FEATURE. Supporting Food Demands and Driving Business Growth FUJITSU. Mansour Zadeh, Global CIO, Smithfield Foods, Inc.

NMP & Health H calls - short overview

a place where locals come for daily practice and lectures a place where international students can come to practice and study

GE Healthcare. Senographe Crystal The choice is crystal clear

GE Healthcare. Senographe Crystal The choice is crystal clear

Driving the Future of Digital Experiences Silvia Boi, Jean Dominique Meunier NEM Executive Board Member

g~:~: P Holdren ~\k, rjj/1~

Comprehensive Research Services

2050 Edinburgh City Vision. One Year On

Translational scientist competency profile

Reflections on Innovation, Science, and Society

Medicines Manufacturing in the UK 2017

BNP Paribas India Solutions Pvt Ltd CSR Policy

Making lives better every day. This is UCB

Start your adventure here.

COUNCIL OF THE EUROPEAN UNION. Brussels, 9 December 2008 (16.12) (OR. fr) 16767/08 RECH 410 COMPET 550

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

NEWS RELEASE. Life sciences companies tout their expertise in India

IFT STRATEGIC PLAN. 2017/18 Strategic Objectives

The prospective contribution and the global and integrated approach to pharmaceutical industry s new challenges.

Commission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )

Highways, ring road, expressways of tomorrow in the Greater Paris

Remarks by Dr. Wang Ruijun at Panel on Science-Policy Interface and Emerging Issues

Digital Wallonia. Digital Strategy for Wallonia. Benoît Hucq General Manager Agence du Numérique Berlin & Munich. February 2016

Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter

EHR Optimization: Why Is Meaningful Use So Difficult?

Driving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China

The value of innovative pharmaceuticals and the potential for Vietnam. Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016

Whiting School of Engineering Interdisciplinary Centers and Institutes. Education. Research. Translation.

Charles Delaunay Institute. Promoting cross-cutting synergy

Wellington City Libraries and Community Spaces. Connecting our Communities

Embraer: Brazil s pioneering aviation giant

SCIENCE, TECHNOLOGY AND INNOVATION SCIENCE, TECHNOLOGY AND INNOVATION FOR A FUTURE SOCIETY FOR A FUTURE SOCIETY

Transcription:

THE PILLARS THAT SUPPORT US

Tradition isn t the enemy, but rather the foundation for audacity. s DR. CHARLES MÉRIEUX

THE PILLARS THAT SUPPORT US s OUR COMMITMENT TO PUBLIC HEALTH s OUR SOCIAL COMMITMENT s OUR VISION BEYOND BORDERS s OUR ROOTS s OUR PIONEERING SPIRIT

THE PILLARS THAT SUPPORT US

Alain Mérieux s entrepreneurial spirit made a unique industrial adventure possible, bringing together men and women from different cultures to serve a common cause: improving public health. Let us think about the entrepreneurial spirit and the factors that motivated us to join an extraordinary group of companies, to address great challenges and sustain our commitment, sometimes in the face of strong headwinds. I invite you to discover the pillars that drive and unite us to successfully carry out our mission. They are unique to our profession, our history and the biomérieux culture. They are uniquely ours. Each of these pillars has meaning for each department, at every level. Beyond the day-to-day, they give purpose and reinvigorate our work at biomérieux on an individual and collective level. s JEAN-LUC BELINGARD

s OUR COMMITMENT TO PUBLIC HEALTH s Serve the greater good for mankind s Place medicine and the interests of patients first and foremost s Meet global public health needs, particularly in the field of infectious diseases

Since its creation, Institut Mérieux works in the interest of public health. Our companies focus on improving health worldwide, taking a holistic approach to contribute to better patient care and the prevention of disease and health hazards. In the field of diagnostics, biomérieux develops solutions that bring high medical value for clinical applications. Through our industrial applications, we contribute to preventing product contamination risks. For the greater good, we make these solutions available to all countries, whatever their resources. The work we carry out in the field is intended to improve public healthcare within the country in question while also contributing to the development of society. We contribute to the sustainability of healthcare infrastructures and systems, in particular, by improving productivity and the control of healthcare spending.

s OUR SOCIAL COMMITMENT s Make diagnostics and quality healthcare accessible to the underprivileged, throughout the world, in partnership with the Mérieux Foundations s Engage responsibly in projects to advance science and research for the greater good s Train employees and support them throughout their career, share know-how

A global healthcare player, Institut Mérieux places the individual at the center of its social commitment. Our expertise in infectious diseases and our international presence give biomérieux an obligation beyond our business activities, as a corporate citizen, to serve the greater good and the communities where we operate. We leverage our areas of excellence to make a difference. Economic success can only follow social commitment.

s OUR VISION BEYOND BORDERS s Take a global perspective, extending over geographic borders s Push beyond scientific and technological limits through a multidisciplinary approach and partnerships s Be open to different cultures and new ideas

Viruses and bacteria know no borders and public health issues must be addressed on a global scale. Our world is shrinking and Institut Mérieux s companies make international development a central part of their strategies. There are many different kinds of borders. biomérieux is open to the cultures of other organizations, such as universities and hospitals. We also extend our reach to complementary scientific fields and technologies. This cross-fertilization will foster new solutions for increasingly complex health problems.

s OUR ROOTS s Take a long-term perspective s Remain independent s Carry on the legacy, based on values that have been handed down through generations: persistence, faithfulness, respect for others and proximity to those in need

The Mérieux family s legacy is a commitment to biology that dates back to 1897, with the creation of Institut Mérieux by Marcel Mérieux, a student of Louis Pasteur and Emile Roux. This was the beginning of an extraordinary bio-industrial adventure in the field of vaccines and, with biomérieux, in in vitro diagnostics. Through the generations, the Mérieux s vision for biology and for the management of men and of companies has remained the same. Now a global leader, biomérieux remains faithful to its origins: Louis Pasteur and France.

s OUR PIONEERING SPIRIT s Strive for excellence s Explore new territories (geographic, technological, scientific, etc.) Innovate in every area Demonstrate audacity and courage, be resilient and adapt to change s Take risks and responsibility for one s actions s Show solidarity with one s team when there are set-backs as well as successes

Being at the forefront of the fight against disease is common to all the Mérieux companies, in every field. This is achieved, among others, through scientific and technological innovation, and spearheading expansion into emerging countries. This pioneering and entrepreneurial spirit propelled Institut Mérieux to become a world leader in the field of human and veterinary vaccines. It drives the creation of many entities since our beginnings, all dedicated to health. This spirit also drives biomérieux s development: our company imagines innovative solutions for our customers, is the first to create subsidiaries in countries like China, initiates new forms of scientific partnerships and joint research units and develops novel human resources policies.

01-13 - Printed in France - Credit photo: Fotolia, GettyImages, GraphicObsession - THERA Conseil - RCS Lyon B 396 160 242. PUBLIC HEALTH SOCIAL COMMITMENT VISION BEYOND BORDERS ROOTS PIONEERING SPIRIT

THE PILLARS THAT SUPPORT US